Electrophysiological Evidence for Impaired Central Pain Modulation in Parkinson's Disease
IF 7.6
1区 医学
Q1 CLINICAL NEUROLOGY
Dilara Kersebaum, Josephine Lassen, Julia Forstenpointner, Manon Sendel, Sophie‐Charlotte Fabig, Sonja Nölker, Juliane Sachau, Steffen Paschen, Daniela Berg, Ralf Baron, Philipp Hüllemann
求助PDF
{"title":"Electrophysiological Evidence for Impaired Central Pain Modulation in Parkinson's Disease","authors":"Dilara Kersebaum, Josephine Lassen, Julia Forstenpointner, Manon Sendel, Sophie‐Charlotte Fabig, Sonja Nölker, Juliane Sachau, Steffen Paschen, Daniela Berg, Ralf Baron, Philipp Hüllemann","doi":"10.1002/mds.70004","DOIUrl":null,"url":null,"abstract":"BackgroundThere is a remarkable overlap between structures involved in pain perception and the pathophysiology of Parkinson's disease (PD). Recent efforts to allocate pain into mechanistic subtypes require a better understanding of central pain processing in PD patients.ObjectivesThe aim of this study was to show electrophysiological evidence for altered central pain processing in a patient group with PD, taking their reported pain, somatosensory profile, and motor symptoms as well as pharmacotherapy into account.MethodsThe laser‐evoked‐potential (LEP)‐habituation paradigm and quantitative sensory testing were applied to PD patients (n = 41) in the off‐<jats:sc>l</jats:sc>‐dopamine (levodopa) state. The development of LEP amplitudes and laser pain ratings over the course of 100 painful stimuli was compared to those of an age‐matched control group (n = 24). The Unified Parkinson's Disease Rating Scale (UPDRS) III and the painDETECT questionnaire and medical history, including pharmacotherapy, were assessed and analyzed in context with LEP and pain habituation aiming to find an electrophysiological proxy for central sensitization.ResultsPatients exhibited a significantly reduced capacity for LEP habituation regardless of clinically reported pain and sensory profile. No association of EEG data has been found with the mean <jats:sc>l</jats:sc>‐DOPA equivalent dose taken by the patients.ConclusionsWe hereby report electrophysiological evidence for an impaired central pain modulation in PD patients regardless of pain presentation and individual sensation. Further exploration of abnormal central pain processing in PD using methods like the LEP habituation paradigm or conditioned pain modulation protocol is needed in larger cohorts. © 2025 The Author(s). <jats:italic>Movement Disorders</jats:italic> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"94 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Movement Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mds.70004","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
BackgroundThere is a remarkable overlap between structures involved in pain perception and the pathophysiology of Parkinson's disease (PD). Recent efforts to allocate pain into mechanistic subtypes require a better understanding of central pain processing in PD patients.ObjectivesThe aim of this study was to show electrophysiological evidence for altered central pain processing in a patient group with PD, taking their reported pain, somatosensory profile, and motor symptoms as well as pharmacotherapy into account.MethodsThe laser‐evoked‐potential (LEP)‐habituation paradigm and quantitative sensory testing were applied to PD patients (n = 41) in the off‐l ‐dopamine (levodopa) state. The development of LEP amplitudes and laser pain ratings over the course of 100 painful stimuli was compared to those of an age‐matched control group (n = 24). The Unified Parkinson's Disease Rating Scale (UPDRS) III and the painDETECT questionnaire and medical history, including pharmacotherapy, were assessed and analyzed in context with LEP and pain habituation aiming to find an electrophysiological proxy for central sensitization.ResultsPatients exhibited a significantly reduced capacity for LEP habituation regardless of clinically reported pain and sensory profile. No association of EEG data has been found with the mean l ‐DOPA equivalent dose taken by the patients.ConclusionsWe hereby report electrophysiological evidence for an impaired central pain modulation in PD patients regardless of pain presentation and individual sensation. Further exploration of abnormal central pain processing in PD using methods like the LEP habituation paradigm or conditioned pain modulation protocol is needed in larger cohorts. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
帕金森病中枢性疼痛调节功能受损的电生理证据
研究背景疼痛感知与帕金森病(PD)的病理生理结构之间存在显著的重叠。最近将疼痛分配到机制亚型的努力需要更好地了解PD患者的中枢性疼痛处理。本研究的目的是显示PD患者组中枢性疼痛加工改变的电生理证据,考虑到他们报告的疼痛、体感特征、运动症状以及药物治疗。方法采用激光诱发电位(LEP)习惯化范式和定量感觉测试对41例左旋多巴(off - l - dopamine, levodopa)状态的PD患者进行研究。在100次疼痛刺激过程中,LEP振幅和激光疼痛评分的发展与年龄匹配的对照组(n = 24)进行了比较。统一帕金森病评定量表(UPDRS) III、painDETECT问卷和病史,包括药物治疗,在LEP和疼痛习惯化的背景下进行评估和分析,旨在找到中枢致敏的电生理代理。结果无论临床报告的疼痛和感觉情况如何,患者表现出LEP习惯化能力显著降低。未发现脑电图数据与患者服用的平均l - DOPA当量剂量相关。结论:我们在此报告PD患者中枢性疼痛调节受损的电生理证据,无论疼痛表现和个体感觉如何。需要在更大的队列中使用LEP习惯化范式或条件疼痛调节方案等方法进一步探索PD中异常的中枢性疼痛加工。©2025作者。Wiley期刊有限责任公司代表国际帕金森和运动障碍学会出版的《运动障碍》。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
来源期刊
期刊介绍:
Movement Disorders publishes a variety of content types including Reviews, Viewpoints, Full Length Articles, Historical Reports, Brief Reports, and Letters. The journal considers original manuscripts on topics related to the diagnosis, therapeutics, pharmacology, biochemistry, physiology, etiology, genetics, and epidemiology of movement disorders. Appropriate topics include Parkinsonism, Chorea, Tremors, Dystonia, Myoclonus, Tics, Tardive Dyskinesia, Spasticity, and Ataxia.